Profile

Forward Pharma A/S (FWP)

$2.8

-0.20 (-6.67%)

Mr. Claus Svendsen
Healthcare
Biotechnology
NASDAQ Capital Market

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.